Advances in the treatment of multiple myeloma

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Leukemia·2018

Drug response prediction in high-risk multiple myeloma.

Gene·2017

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Nature communications·2017

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Leukemia·2017

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Blood cancer journal·2017

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

Leukemia·2016

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.

Advances in internal medicine·2002

Pathogenesis and treatment of cardiomyopathy.

Advances in internal medicine·2002

Update on the prevention, diagnosis, and treatment of Lyme disease.

Advances in internal medicine·2001

Radiocopper in BCMA-targeted immunotheranostics of myeloma.

Theranostics·2026

hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma.

Theranostics·2026

Nano-flow intracalvariosseous infusion enables skull-to-brain delivery of BBB-impermeable molecular and nanoscale agents in mice and rabbits.

Theranostics·2026

Design of a Pragmatic Randomized Controlled Trial for Comparing the Michigan Screening and Intervention for Glaucoma and Eye Health and Telemedicine Protocol with Usual Care for Disease Detection.

Clinical ophthalmology (Auckland, N.Z.)·2026

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.

Theranostics·2026

Correction: Editorial: Advancements in meningioma management: from imaging techniques to personalized medicine approaches.

Frontiers in neurology·2026

Related Experiment Videos

Advances in the treatment of multiple myeloma

Related Concept Videos

Combination of flow cytometry and functional imaging for monitoring of residual disease in myeloma.

Drug response prediction in high-risk multiple myeloma.

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing.

Integrative network analysis identifies novel drivers of pathogenesis and progression in newly diagnosed multiple myeloma.

Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker.

Hyperhaploidy is a novel high-risk cytogenetic subgroup in multiple myeloma.

A risk factor for atherosclerosis: triglyceride-rich lipoproteins.

Pathogenesis and treatment of cardiomyopathy.

Update on the prevention, diagnosis, and treatment of Lyme disease.

Radiocopper in BCMA-targeted immunotheranostics of myeloma.

hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma.

Nano-flow intracalvariosseous infusion enables skull-to-brain delivery of BBB-impermeable molecular and nanoscale agents in mice and rabbits.

Design of a Pragmatic Randomized Controlled Trial for Comparing the Michigan Screening and Intervention for Glaucoma and Eye Health and Telemedicine Protocol with Usual Care for Disease Detection.

Erratum: Co-delivery of siPTPN13 and siNOX4 via (myo)fibroblast-targeting polymeric micelles for idiopathic pulmonary fibrosis therapy: Erratum.

Correction: Editorial: Advancements in meningioma management: from imaging techniques to personalized medicine approaches.

Related Experiment Videos

Advances in the treatment of multiple myeloma

Related Concept Videos

Related Articles